Details of the Drug Reposition

General Information of This Drug (ID: DMFUXSP)

• Drug Name: CLL442 (DMFUXSP)

Information on Drug Reposition of This Drug

2 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Squamous cell carcinoma	DISQVIFL	2B60-2D01	Phase 1/2	[1]
Cutaneous squamous cell carcinoma	DIS3LXUG	2C30	Phase 1/2	[2]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)